Clinical Trial Results: A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating aticaprant plus antidepressant to prevent return of depressive symptoms in adults with Major Depressive Disorder and anhedonia; study t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anhedonia
• Major Depressive Disorder

Drugs mentioned

• Aticaprant (Aticaprant)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major, Anhedonia | Phase 3 | Status: TERMINATED | Results posted: 2026-06-08